On top of all these engineering issues, many cancer cells are argininosuccinate synthase (ASS)-positive but ornithine transcarbamylase (OTC)-negative [8], meaning that they are intrinsically resistant to ADI-PEG20 [5,7,8,11,18,19,20,21,22]. This evidence concerns the gene ASS1 and cancer.